{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:36:13Z","timestamp":1767148573802,"version":"build-2238731810"},"reference-count":29,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,25]],"date-time":"2017-04-25T00:00:00Z","timestamp":1493078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011094","name":"Public Health Agency of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011094","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012395","name":"Canadian Immunization Research Network","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012395","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000008","name":"Health Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000008","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ontario Ministry of the Environment","award":["MOP-81285"],"award-info":[{"award-number":["MOP-81285"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.vaccine.2017.04.057","type":"journal-article","created":{"date-parts":[[2017,4,29]],"date-time":"2017-04-29T03:00:27Z","timestamp":1493434827000},"page":"3050-3055","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Seroprevalence of rubella antibodies and determinants of susceptibility to rubella in a cohort of pregnant women in Canada, 2008\u20132011"],"prefix":"10.1016","volume":"35","author":[{"given":"Nicolas L.","family":"Gilbert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny","family":"Rotondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janna","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsey","family":"Sherrard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William D.","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian J.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.04.057_b0005","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1016\/S0140-6736(14)60539-0","article-title":"Rubella","volume":"385","author":"Lambert","year":"2015","journal-title":"Lancet"},{"issue":"8302","key":"10.1016\/j.vaccine.2017.04.057_b0010","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0140-6736(82)92677-0","article-title":"Consequences of confirmed maternal rubella at successive stages of pregnancy","volume":"2","author":"Miller","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2017.04.057_b0015","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/GRF.0b013e31824df256","article-title":"Measles, mumps, and rubella","volume":"55","author":"White","year":"2012","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2017.04.057_b0020","series-title":"Control of communicable diseases manual","first-page":"529","article-title":"Rubella","author":"Duclos","year":"2008"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2017.04.057_b0025","doi-asserted-by":"crossref","first-page":"S585","DOI":"10.1093\/infdis\/jir406","article-title":"Rubella elimination, the Canadian experience","volume":"204","author":"Macey","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.04.057_b0030","unstructured":"Public Health Agency of Canada. Elimination of measles, rubella and congenital rubella syndrome in Canada. Documentation and verification report submitted to the Pan American Health Organization\/World Health Organization; 2011."},{"key":"10.1016\/j.vaccine.2017.04.057_b0035","unstructured":"National Advisory Committee on Immunization. Rubella vaccine. In: Canadian Immunization Guide. <https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/healthy-living\/canadian-immunization-guide-part-4-active-vaccines\/page-20-rubella-vaccine.html> [accessed on April 13, 2017]."},{"key":"10.1016\/j.vaccine.2017.04.057_b0040","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0264-410X(97)00114-X","article-title":"Twenty-three-year follow-up study of rubella antibodies after immunization in a closed population, and serological response to revaccination","volume":"15","author":"Asahi","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.04.057_b0045","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/00006454-199608000-00010","article-title":"Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years","volume":"15","author":"Johnson","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2017.04.057_b0050","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1086\/513967","article-title":"Serum levels of rubella virus antibodies indicating immunity: response to vaccination of subjects with low or undetectable antibody concentrations","volume":"175","author":"Matter","year":"1997","journal-title":"J Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2017.04.057_b0055","doi-asserted-by":"crossref","first-page":"S579","DOI":"10.1093\/infdis\/jir447","article-title":"Global use of rubella vaccines, 1980\u20132009","volume":"204","author":"Strebel","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.04.057_b0060","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1345\/aph.1Q318","article-title":"The vaccine-autism connection: a public health crisis caused by unethical medical practices and fraudulent science","volume":"45","author":"Flaherty","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.vaccine.2017.04.057_b0065","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S1701-2163(16)32740-2","article-title":"Rubella in pregnancy","volume":"30","author":"Dontigny","year":"2008","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.vaccine.2017.04.057_b0070","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/1471-2334-13-362","article-title":"Rubella immunity among prenatal women in Ontario, 2006\u20132010","volume":"13","author":"Lim","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2017.04.057_b0075","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.vaccine.2014.12.022","article-title":"Determining rubella immunity in pregnant Alberta women 2009\u20132012","volume":"33","author":"Lai","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.04.057_b0080","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/ppe.12061","article-title":"Cohort profile: the maternal-infant research on environmental chemicals research platform","volume":"27","author":"Arbuckle","year":"2013","journal-title":"Paediatr Perinat Epidemiol"},{"key":"10.1016\/j.vaccine.2017.04.057_b0085","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1128\/CVI.00603-12","article-title":"Investigation into low-level anti-rubella virus IgG results reported by commercial immunoassays","volume":"20","author":"Dimech","year":"2013","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2017.04.057_b0090","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/ajcp\/106.2.170","article-title":"Rubella immunity. Defining the level of protective antibody","volume":"106","author":"Skendzel","year":"1996","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.vaccine.2017.04.057_b0095","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.vaccine.2015.02.043","article-title":"Rubella susceptibility in pregnant women and results of a postpartum immunization strategy in Catalonia, Spain","volume":"33","author":"Vilajeliu","year":"2015","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2017.04.057_b0100","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1590\/S1020-49892007000700005","article-title":"A rubella serosurvey in postpartum women in the three regions of Peru","volume":"22","author":"Su\u00e1rez-Ognio","year":"2007","journal-title":"Rev Panam Salud Publica"},{"key":"10.1016\/j.vaccine.2017.04.057_b0105","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.vaccine.2011.11.045","article-title":"Seroprevalence of low rubella IgG antibody levels among antenatal women in England tested by NHS Blood and Transplant: 2004\u20132009. Is rubella susceptibility increasing?","volume":"30","author":"Byrne","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.04.057_b0110","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1080\/21645515.2015.1128600","article-title":"How to determine protective immunity in the post-vaccine era","volume":"12","author":"Charlton","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2017.04.057_b0115","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1086\/505947","article-title":"Rubella immunity levels in the United States population: has the threshold of viral elimination been reached?","volume":"43","author":"Hyde","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.04.057_b0120","unstructured":"Statistics Canada. CANSIM Table 051-0001: Estimates of population, by age group and sex for July 1, Canada, provinces and territories, annual. <http:\/\/www5.statcan.gc.ca\/cansim\/a26?id=510001> [accessed April 13, 2017]."},{"key":"10.1016\/j.vaccine.2017.04.057_b0125","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S1701-2163(16)34171-8","article-title":"Rates of rubella immunity among immigrant and non-immigrant pregnant women","volume":"31","author":"McElroy","year":"2009","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.vaccine.2017.04.057_b0130","doi-asserted-by":"crossref","first-page":"20","DOI":"10.7326\/0003-4819-146-1-200701020-00005","article-title":"Susceptibility to measles, mumps, and rubella in newly arrived adult immigrants and refugees","volume":"146","author":"Greenaway","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.vaccine.2017.04.057_b0135","doi-asserted-by":"crossref","unstructured":"Gilbert NL, Gilmour H, Wilson SE, Cantin L. Determinants of non-vaccination and incomplete vaccination in Canadian toddlers. Hum Vaccin Immunother 2017. http:\/\/dx.doi.org\/10.1080\/21645515.2016.1277847 [in press].","DOI":"10.1080\/21645515.2016.1277847"},{"key":"10.1016\/j.vaccine.2017.04.057_b0140","first-page":"1091","article-title":"Evaluation of rubella screening in pregnant women","volume":"159","author":"Gyorkos","year":"1998","journal-title":"CMAJ"},{"key":"10.1016\/j.vaccine.2017.04.057_b0145","unstructured":"Public Health Agency of Canada. What Mothers Say: the Canadian Maternity Experiences Survey. 2009. <http:\/\/publications.gc.ca\/collections\/collection_2009\/aspc-phac\/HP5-74-2-2009E.pdf>."}],"updated-by":[{"DOI":"10.1016\/j.vaccine.2020.06.005","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:00:00Z","timestamp":1594684800000}}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17305492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17305492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T17:12:11Z","timestamp":1589735531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17305492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":29,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0264410X17305492"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.04.057","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seroprevalence of rubella antibodies and determinants of susceptibility to rubella in a cohort of pregnant women in Canada, 2008\u20132011","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.04.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2017 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}